Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000354817

Medchemexpress LLC Blu-945 | 2660250-10-0 | 99.6% | C28H37FN6O3S | 1 ML
SDP

Catalog No. 5000354817
Encompass_Preferred

BLU-945 is a potent, highly selective, reversible, and orally active epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKIs). It effectively inhibits EGFR with L858R and/or exon 19 deletion mutation, T790M mutation, and C797S mutation, making it suitable for lung cancer research, including non-small cell lung cancer (NSCLC).

  • Potent, highly selective, reversible, and orally active
  • Inhibits EGFR with L858R, exon 19 deletion, T790M, and C797S mutations
  • Used for research of lung cancer, including non-small cell lung cancer (NSCLC)
  • Demonstrates anti-tumor activity in triple-mutant Osimertinib-resistant models

Catalog No. 50-003-54817 Supplier Medchemexpress LLC Supplier No. HY14468010MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

BLU-945 is a potent, highly selective, reversible, and orally active epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKIs). It effectively inhibits EGFR with L858R and/or exon 19 deletion mutation, T790M mutation, and C797S mutation, making it suitable for lung cancer research, including non-small cell lung cancer (NSCLC).

  • Potent, highly selective, reversible, and orally active
  • Inhibits EGFR with L858R, exon 19 deletion, T790M, and C797S mutations
  • Used for research of lung cancer, including non-small cell lung cancer (NSCLC)
  • Demonstrates anti-tumor activity in triple-mutant Osimertinib-resistant models

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.